Background
==========

Quinolone resistance in *Enterobacteriaceae*results mainly from mutations in type II DNA topoisomerase genes\[[@B1]\] and/or changes in the expression of outer membrane and efflux pumps\[[@B2]\]. Recently, studies have shown that plasmid-mediated resistance mechanisms also play a significant role in fluoroquinolone resistance, and its prevalence is increasing worldwide \[[@B3]\]. *qnrA*is the plasmid-mediated quinolone resistance gene encoding a 218 amino acid protein of the pentapeptide family that protects DNA gyrase from quinolone inhibition\[[@B4]\]. The new plasmid-mediated quinolone resistance genes, *qnrB*and *qnrS*, have been reported in clinical isolates\[[@B5],[@B6]\]. In China, the presence of the *qnr*gene in clinical isolates of *Enterobacteriaceae*from Shanghai \[[@B7]\] and Anhui\[[@B8]\] has been reported, but this transmissible quinolone resistance gene has not been detected in strains isolated singly from pediatric patients. Because quinolones associated with a variety of adverse side effects on children, they are not authorized for pediatric use. Therefore, the objective of this study was to screen for the presence of the *qnr*gene in clinical ciprofloxacin-resistant isolates of *Escherichia coli*and *Klebsiella pneumoniae*from pediatric patients in China.

Methods
=======

Bacterial strains
-----------------

Three hundred thirty-five *Escherichia coli*and 392 *Klebsiella pneumoniae*non-replicate clinical isolates were collected from five children\'s hospitals located in Beijing, Shanghai, Guangzhou, and Chongqing from January 2005 to December 2006. Each hospital is a general pediatric hospital locally affiliated to a university. The isolates were identified at the participating hospitals by routine methodology at each laboratory, and then were transported to Beijing Children\'s Hospital for further analysis. All isolates were screened for ciprofloxacin resistance by disk method according to the criteria of NCCLS \[[@B9]\]. The screening showed 146 *Escherichia coli*and 67 *Klebsiella pneumoniae*isolates were ciprofloxacin-resistant. Additional strain used was *E. coli*J53Az^R^(resistant to azide) as a recipient of the conjugation experiment

Screening for the *qnrAM*, *qnrB*, and *qnrS*gene in clinical strains
---------------------------------------------------------------------

The 213 ciprofloxacin-resistant strains of *E. coli*and *K. pneumoniae*were screened by multiplex PCR amplification of *qnrA, qnrB*, and *qnrS*as previously described\[[@B10]\]. Colonies were transferred to an Eppendorf tube filled with water and boiled to prepare DNA templates for PCR. The primers used for *qnrA, qnrB, and qnrS*were as follows: \'5-ATTTCTCACGCCAGGATTTG-3\' and 5\'-GATCGGCAAAGGTTAGGTCA-3\' for *qnrA*for a 516-bp product, 5\'-GATCGTGAAAGCCAGAAAGG-3\' and 5\'-ACGATGCCTGGTAGTTGTCC-3\' for *qnrB*for a 469-bp product, and 5\'-ACGACATTCGTCAACTGCAA-3\' and 5\'-TAAATTGGCACCCTGTAGGC-3\' for *qnrB*for a 417-bp product. The protocol for the PCR condition was: 94°C for 45 s, 53°C for 45 s, and 72°C for 60 s, with a cycle number of 32, and without DNA template as negative controls in each run. Amplification products were provisionally identified by their size in ethidium bromide-stained agarose gels. The positive amplified PCR product for *qnrA, qnrB*, and *qnrS*was analyzed with an automated DNA sequencing system. The results of DNA sequences were compared with the BLAST online search engine from GenBank at the National Center for Biotechnology Information Web site: <http://www.ncbi.nlm.nih.gov/blast>.

Conjugation experiments
-----------------------

All positive *qnr*strains were tested for transferred quinolone resistance by conjugation experiments carried out in Luria Broth with *E. coli*J53Az^R^as the recipient. The cultures of donor and recipient cells were incubated via shaking at 37°C in logarithmic phase, and then 0.5 mL of both cultures was added to 4 mL of fresh LB and incubated overnight without shaking. Transconjugants were selected on trypticase soy agar (TSA) plates with sodium azide (100 μg/mL from Sigma Chemical Co., St. Louis, MO) for counter selection and ampicillin (100 μg/mL from Oxoid) to select for plasmid-encoded resistance. To determine if quinolone resistance was cotransferred, colonies were replica-plated onto TSA with and without ciprofloxacin (0.06 μg/mL; Oxoid). The PCR experiments confirmed transconjugants carrying the same *qnr*gene as their donors.

Antimicrobial susceptibility profiles
-------------------------------------

MICs for the 19 positive *qnr*isolates, recipient (J53 Az^R^), and transconjugant strains were measured by agar dilution in accordance with the guidelines of the NCCLS. The antimicrobials tested were ampicillin/clavulanic acid, cefotaxime, ceftazidime, cefoperazone, cefoxitin, cefepime, aztreonam, imipenem, ciprofloxacin, ofloxacin, amikacin, and gentamicin (Oxoid, England). Quality control was performed by testing *Escherichia coli*ATCC25922. Isolates which showed MICs ≥ 2 μg/ml for cefotaxime and/or ceftriaxone and/or ceftazidime and/or aztreonam were considered as ESBL producers. The ESBL phenotype was confirmed by using clavulanic acid (Oxoid, England) according to the manufacturer\'s recommendation.

Strain typing by ERIC-PCR
-------------------------

The 11 positive *qnr Escherichia coli*strains and 8 positive *qnr Klebsiella pneumoniae*strains were typed by ERIC-PCR. Total DNA from *qnr*positive isolates was analyzed by ERIC sequence PCR with the ERIC1R (*5\'-ATGTAAGCTCCTGGGGATTCAC-3\'*) and ERIC2 (*5\'-AAGTAAGTGACTGGGGTGAGCG-3\'*) primers, and PCR was performed as previously described \[[@B11]\]. ERIC-PCR was performed briefly using the following program parameters: denaturation at 94°C for 1 s, annealing at 52°C for 10 s, and extension at 72°C for 35 s for 30 cycles, followed by a final extension at 72°C for 4 min. Amplicons were separated on a 1.5% agarose gel containing ethidium bromide (5 μg/mL) at 60 V for 3 hours. The gels were photographed and digitized. Isolates were considered different if their profiles differed by two or more bands\[[@B12]\].

Results
=======

Screening for the qnr genes
---------------------------

Nineteen ciprofloxacin-resistant clinical isolates, including eleven *E. coli*and eight *K. pneumoniae*strains, were positive for the *qnr*gene. Table [1](#T1){ref-type="table"} shows the clinical characteristics of these isolates and the distribution of *qnrA*, *qnrB*, or *qnrS*. The sequences of *qnr*genes were all identical to those of *qnrA*(EU195836), *qnrB*(EU443840), and *qnrS*(EU391634) with GenBank, respectively.

###### 

Clinical characteristics and *qnr*genotype of the *qnr*-positive isolates

  Number of Strains   Specimen            Sex   Age         Diagnoses        *qnr*                ESBL
  ------------------- ------------------- ----- ----------- ---------------- -------------------- ------
  *E. coli*                                                                                       
                                                                                                  
  05B239              sputum              m     2 months    Pneumonia        *qnrA, qnrB, qnrS*   \-
  05C2795             sputum              f     15 days     Pneumonia        *qnrA*               \+
                                                                                                  
  05G1844             vulvar secretions   f     5 years     Vulvitis         *qnrA, qnrS*         \-
  05G1889             urine               m     2 months    Hydronephrosis   *qnrA, qnrB*         \+
  05SB14              sputum              f     24 days     Pneumonia        *qnrS*               \+
  05SB25              urine               m     5 months    UTI^a^           *qnrA, qnrB*         \+
  05SB47              tracheal            f     12 months   Pneumonia        *qnrA, qnrB*         \+
  06G60               blood               m     3 years     ALL^b^           *qnrA*               \+
  06G62               sputum              f     24 days     Pneumonia        *qnrS*               \+
                                                                                                  
  06G99               sputum              f     4 months    Pneumonia        *qnrA, qnrB*         \-
  06SA30              sputum              f     2 months    Pneumonia        *qnrS*               \+
  *K. pneumoniae*                                                                                 
  05C2978             sputum              m     9 months    Pneumonia        *qnrB*               \+
  05G44               sputum              f     1 months    Pneumonia        *qnrB*               \+
  05SA32              sputum              f     21 months   Pneumonia        *qnrS*               \+
  06B295              sputum              m     11 days     Pneumonia        *qnrB*               \+
  06B700              urine               f     4 years     UTI^a^           *qnrB*               \+
  06C3889             sputum              f     4 days      Pneumonia        *qnrS*               \+
  06C5524             sputum              f     3 months    Pneumonia        *qnrB*               \+
  06SB60              sputum              m     3 months    Pneumonia        *qnrS*               \+

^a^UTI, Urinary tract infection;

^b^ALL, Acute lymphoblastic leukemia.

Conjugation and antimicrobial susceptibility
--------------------------------------------

Quinolone resistance could be transferred by conjugation in two of eight of *Klebsiella pneumoniae qnr*-positive donors. One *qnrB*-positive and one *qnrS*-positive transconjugant were obtained. PCR experiments confirmed that the transconjugants harbored the same *qnr*gene as their donors. Table [2](#T2){ref-type="table"} shows the susceptibilities of the *qnr*-positive clinical isolates for the selected antibiotics. Most isolates were resistant to cephalosporin, aztreonam, and aminoglycosides, whereas all of the strains were susceptible to imipenem. Eight of eleven *qnr*positive isolates of *Escherichia coli*and all eight *qnr*positive isolates of *Klebsiella pneumoniae*were phenotypic ESBL producers, respectively. Antibiotic susceptibilities for the two transconjugants showed that the ciprofloxacin resistance MIC value increased 32- and 1024-fold, respectively; meanwhile, oflaxacin resistance MIC value increased 2- and 32-fold, respectively.

###### 

Resistance profiles of the *qnr*positive strains and transconjugants

  Strain            MIC(μg/ml)                                                                                      
  ----------------- ------------ -------- -------- -------- ----- -------- -------- ----- -------- -------- ------- ------
  *E. coli*                                                                                                         
  05B239            32           \> 512   512      32       32    512      0.25     64    4        128      64      32
  05C2795           128          512      64       256      512   16       0.5      256   16       256      16      32
  05G1844           32           512      64       8        32    8        0.125    16    4        128      64      32
  05G1889           32           512      \> 512   32       32    128      0.25     32    8        128      64      64
  05SB14            16           \> 512   128      8        32    16       0.125    8     8        256      64      16
  05SB25            32           \> 512   \> 512   128      32    128      0.125    64    4        128      64      32
  05SB47            32           \> 512   \> 512   512      16    \> 512   0.25     256   8        128      256     64
  06G60             32           512      512      32       16    128      0.25     64    4        128      32      16
  06G62             16           512      512      8        32    32       0.125    8     8        128      64      32
  06G99             64           \> 512   \> 512   512      512   128      0.25     256   4        128      64      64
  06SA30            32           512      \> 512   8        32    32       0.25     16    16       256      4       32
  *K. pneumoniae*                                                                                                   
  05C2978^b^        32           128      128      512      16    64       0.125    128   4        32       256     128
  05SA32^b^         32           256      256      512      16    128      0.125    128   8        2        4       8
  05G44             128          \> 512   \> 512   \> 512   512   512      1        512   8        32       4       4
  06B295            32           \> 512   128      64       16    64       1        64    8        2        4       8
  06B700            32           512      512      256      256   128      0.25     128   8        128      32      8
  06C3889           32           \> 512   256      512      32    64       0.125    256   \> 512   \> 512   256     256
  06C5524           32           256      128      512      16    64       0.5      512   \> 512   512      64      32
  06SB60            32           \> 512   \> 512   64       32    512      0.25     256   4        128      4       32
  Recipients                                                                                                        
  J53               16           2        0.125    0.25     2     1        0.0625   4     8        0.25     0.125   0.25
  Transconjugants                                                                                                   
  Tc 05C2978^c^     32           128      128      512      64    32       0.125    128   8        512      128     8
  Tc^b^05SA32^c^    32           512      512      512      128   256      0.25     128   16       128      4       0.5

^a^AMC, amoxicillin/clavulanic acid; CFP, cefoperazone; CTX, cefotaxime; CAZ, cefotaxime; FOX, cefoxitin; FEP, cefepime; IPM/CS, imipenem/cilastatin; ATM, aztreonam; AMK, amikacin; GEN, gentamicin; CIP, ciprofloxacin; OFX, ofloxacin.

^b^domor;

^c^Tc, transconjugants

Strain typing by ERIC-PCR
-------------------------

The positive qnr isolates of *E. coli*, and *K. pneumoniae*showed different DNA banding patterns, indicating that they were not clonally related.

Discussion
==========

This study is the first report on the presence of the *qnr*gene in clinical isolates from pediatric patients in China. The prevalence rates of *qnr*among ciprofloxacin-resistant isolates of *E. coli*and *K*. were 7.5% (11 of 146), and 11.9% (8 of 67), respectively. The *qnr*rate in isolates of *Escherichia coli*analyzed in this study was similar to the prevalence in Shanghai, China, wherein there was 8% (6 of 78 strains) of ciprofloxacin-resistant clinical isolates of *E. coli*\[[@B7]\]. These rates are lower than the prevalence of *qnrA*detected among ceftazidime-resistant or ciprofloxacin-resistant strains (24%) of *Enterobacter*in USA\[[@B13]\]. Among the three groups of the *qnr*gene, *qnrA*was more prevalent (8 of 11) in *Escherichia coli*strains, whereas *qnrB*was more prevalent (5 of 8) in the *Klebsiella pneumoniae*isolates. As there are differences in the criteria for testing strains, evaluating the precise prevalence of plasmid-mediated quinolone resistance was difficult.

It should be noted that all the positive *qnr*isolates were distributed in pediatric patients: more than one-third were isolated from children younger than one year of age, and nearly one-fourth were isolated from neonates. Because of the variety of adverse side effects of quinolones in children, hospitals are not advised to use them on children. In China, quinolones are not used on children younger than 16 years old. Presumably, the source of the *qnr*gene might not be directly associated with the selective pressure caused by the quinolones used in pediatrics, but it could be related to horizontal transmission from adults or other reservoir. Recent findings showed that these genes come from environmental gram-negative bacterial species, such as *Shewanella algae*, the progenitor of the *qnrA*genes \[[@B14]\], and *Vibrio splendidus*or *Aeromonas spp*., the progenitor of *qnrS*genes\[[@B15],[@B16]\]. This shows that the aquatic environment is an important reservoir of novel antibiotic resistance determinants. Quinolones are antimicrobial agents extensively used in aquaculture and are stable molecules in water \[[@B17]\]. Exposure to lower concentrations of quinolones increases the chance for seletion of resistance. Therefore, they may be the source of an important driving force for the selection of quinolone resistance. Another study showed that *qnrS*genes were identified from *E. coli*and *E. cloacae*isolated from zoo animals in Japan, suggesting that animals could be a potential reservoir of quinolone-resistant bacteria\[[@B18]\]. Quinolones are the most common antimicrobial used in animals, the annual consumption of which is about 470 tons in China \[[@B19]\]. In the present study, more than two-thirds of *qnr*positive strains were isolated from sputum sample. These strains may be confined in children\'s respiratory tract, which come from the contaminated environment.

This study showed that most *qnr*positive strains were ESBL producers, indicating the relationship between the *qnr*gene and ESBL. Other studies have shown that several *qnrA*-positive isolates express ESBL \[[@B7],[@B20],[@B21]\]. A *qnrS*gene on a plasmid encoding ESBL in a *K. pneumoniae*strain also has been reported in Taiwan, China \[[@B22]\]. Therefore, the fact that expanded-spectrum cephalosporins are widely used among Chinese children may also contribute to the presence of the *qnr*gene. Another study by the present researchers suggested that third-generation cephalosporins are commonly used in pediatric patients (data not published).

Conjugation experiments showed that only two *qnr*-positive *K. pneumoniae*strains were able to transfer the *qnr*gene in transconjugants. This transferability was similar to the findings of other studies, which also showed that not all *qnr*-positive strains were able to transfer quinolone resistance \[[@B23],[@B24]\]. The lower resistance to ciprofloxacin and oflaxacin in these two transconjugants than their donor strains may imply the presence of additional chromosomal resistance mutations. The results of ERIC-PCR showed that the positive *qnr*strains have different types of DNA band, thereby suggesting that the *qnr*in clinical isolates was not caused by the spread of identical strains.

Although the number of data points is limited, this report confirms the spread of the plasmid-mediated quinolone resistance *qnr*gene in *E. coli*and *K. pneumoniae*strains isolated from pediatric patients. Still, however, further research is needed to understand the influence of this gene on quinolone resistance for pediatric patients in China.

Conclusion
==========

The prevalence rates of *qnr*among the clinical isolates of ciprofloxacin resistance in *E. coli*and *K. pneumoniae*were 7.5% (11 of 146) and 11.9% (8 of 67), respectively. The transferability of fluoroquinolone resistance because of the *qnr*gene among *E. coli*and *K. pneumoniae*strains shows that plasmid-mediated quinolone resistance has been spread in pediatric patients in China.
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